🔎 Trials Near Me

Akèy › Mediloblastom › Distrik Columbia › Washington

Etid klinik pou Mediloblastom nan Washington, DC

9 etid pou Mediloblastom ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease

Ap rekriteFaz 1/2
  • Children's National Hospital, Washington D.C.
Laj 1 a 25 · Tout sèks · Mizajou Sep 28, 2026 · NCT07346157

Digoxin Medulloblastoma Study

Ap rekriteFaz 2
  • Children's National Medical Center, Washington D.C.
12 Months – 30 Years · Tout sèks · Mizajou Aug 26, 2026 · NCT06701812

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Ap rekriteFaz 3
  • Children's National Medical Center, Washington D.C.
Laj 4 a 21 · Tout sèks · Mizajou Aug 25, 2026 · NCT05382338

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Ap rekriteFaz 2
  • Children's National Medical Center, Washington D.C.
Laj 3 a 39 · Tout sèks · Mizajou Aug 24, 2026 · NCT05096481

PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

Ap rekriteFaz 1/2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 120 · Tout sèks · Mizajou Aug 12, 2026 · NCT06161519

Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma

Ap rekrite
  • Children's National Hospital, Washington D.C.
12 Months – 39 Years · Tout sèks · Mizajou Aug 11, 2026 · NCT05057702

Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma

Ap rekriteFaz 1
  • Children's National Hospital, Washington D.C.
Laj 4 a 30 · Tout sèks · Mizajou Aug 7, 2026 · NCT06514898

Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)

Ap rekriteFaz 1
  • Children's National Hospital, Washington D.C.
Laj 1 a 30 · Tout sèks · Mizajou Jun 17, 2026 · NCT06193759

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

Ap rekriteFaz 1
  • National Institutes of Health, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Dec 18, 2025 · NCT04541082

Etid Mediloblastom nan lòt vil

Lòt etid nan Washington

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.